Byung-Tae Noh
Chief Executive Officer at DAE HWA PHARMACEUTICAL CO., LTD.
Net worth: 431 023 $ as of 2024-05-30
Byung-Tae Noh active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DAE HWA PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 2015-03-19 | - |
| Chairman | 2015-03-19 | - | |
| Corporate Officer/Principal | 1985-12-14 | 2015-03-19 |
Career history of Byung-Tae Noh
Former positions of Byung-Tae Noh
| Companies | Position | Start | End |
|---|---|---|---|
RedoxBio Co., Ltd.
 RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea. | Director/Board Member | - | - |
Training of Byung-Tae Noh
| Daegu University | Undergraduate Degree |
Statistics
International
| South Korea | 4 |
Operational
| Chief Executive Officer | 1 |
| Chairman | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| DAE HWA PHARMACEUTICAL CO., LTD. | Health Technology |
 | Health Technology |
- Stock Market
- Insiders
- Byung-Tae Noh
- Experience
